艾名医学
艾名医学
Dr. Xing graduated from NUS and has extensive R&D experience in organoid disease modeling, oncology drug screening and neurodegenerative diseases. After graduating from NUS, Dr. Xing has been working on organoid product development and market expansion in STEMCELL Technologies. She joined AimingMed in 2021, in charge of R&D and management of oncology organoid product pipeline, with 18 patents filed and 10 patents granted.
尊敬的 先生/女士
您已注册成功，注册信息及注意事项已发到联系人及参会人邮箱，请注意查收。如未收到，请联系大会联系人。
